In March 2023, we launched a survey of PsychU members to assess the stigma associated with AAD. This infographic summarizes the results of the survey. Over a 30-day period, 194… Read More
Explore with us, the barriers to treatment access and challenges faced by the medical community in delivering equitable care to agitated individuals with Alzheimer’s Disease from diverse backgrounds. Read More
This presentation introduces the improved coding options, and describes the coding structure format used in the updated dementia code sections. New code guidance for agitation in Alzheimer’s dementia is compared… Read More
Research has shown that in patients with Alzheimer’s dementia, agitation is associated with tau pathology and neurodegeneration in the prefrontal cortex and amygdala regions of the brain. Read More
This webinar dives into the unmet needs within this patient population and feature experts in the management of AAD within the primary care setting. Specifically, presenters review the prevalence of… Read More
Tau pathology and neurodegeneration in key prefrontal and subcortical brain regions may increase the risk of developing agitation in Alzheimer’s dementia. Read More
A critical part of managing Alzheimer’s Disease (AD) is the treatment of neuropsychiatric features. Download this informative infographic for reference. Read More